Genevation

Genevation is a biotechnology company developing personalised mRNA cancer vaccines using AI-assisted tumour neoantigen identification.

Its platform analyses tumour sequencing data to select patient-specific targets and combines computational vaccine design with cell-free RNA manufacturing. The company reports preclinical research in lung, skin and colorectal cancer models and is developing a workflow intended to shorten individualised vaccine production. Its work spans immuno-oncology, molecular biology and therapeutic RNA development.